Oak vs Embody: Which GLP-1 Clinic Is Better in 2026?
Summarize this page with
Short answer
Oak wins overall, scoring 7.7/10 vs 7.2/10 — mainly on transparency. If price is your priority, Embody is cheaper at $79/mo.
Oak wins overall, scoring 7.7/10 vs 7.2/10. If price is your priority, Embody is cheaper at $79/mo.
Oak
A low-priced, longevity-minded option — compounded semaglutide from $119/mo and tirzepatide from $199/mo, after an async licensed-provider review, with free shipping, health coaching and optional NAD+/peptide add-ons.
from $119/mo
Visit OakEmbody
The format-flexible pick — compounded semaglutide and tirzepatide as either a weekly injection or a daily oral 'gum', with a low teaser price and unlimited 24/7 messaging.
from $79/mo
Visit EmbodyOak vs Embody, side by side
| Feature | Oak | Embody |
|---|---|---|
| Our score | 7.7/10 | 7.2/10 |
| Starting price | $119/mo | $79/mo |
| Medication types | compounded semaglutide, compounded tirzepatide, oral / sublingual, oral drops | compounded semaglutide, compounded tirzepatide, oral (gum) |
| Best for | — | Needle-Free GLP-1 |
| Overall ranking | #4 | #17 |
| Price & Value (25%) | 8.5 | 8.5 |
| Clinical Oversight (30%) | 7.5 | 7.5 |
| Medication Options (20%) | 8.0 | 8.0 |
| Transparency (25%) | 7.0 | 5.0 |
Sources: Oak pricing verified on oaklovesyou.com, Embody pricing verified on joinem.co
Pros & cons
Oak
Pros
- + One of the cheapest entries we track ($119/mo semaglutide)
- + Needle-free oral route plus NAD+ and longevity add-ons
- + Licensed-provider review (no video call), free shipping, no subscription lock-in
Cons
- − Weaker on Transparency (7.0/10)
- − Weaker on Clinical Oversight (7.5/10)
- − Weaker on Medication Options (8.0/10)
Embody
Pros
- + Choice of weekly injection or needle-free oral gum
- + Fast, free expedited shipping; unlimited 24/7 support
- + LegitScript-certified, clinician-reviewed intake
Cons
- − Weaker on Transparency (5.0/10)
- − Weaker on Clinical Oversight (7.5/10)
- − Weaker on Medication Options (8.0/10)
The bottom line
After scoring all 30 clinics on our 4-criterion rubric (price & value, clinical oversight, medication options and transparency), Oak (7.7/10) comes out ahead of Embody (7.2/10) — but the right choice still depends on what matters most to you.
Choose Oak if you want this option — from $119/mo.
Visit Oak →Choose Embody if you want needle-free glp-1 — from $79/mo.
Visit Embody →Editor's overall pick
Not sold on either? Our highest-rated clinic overall is Wellorithm (8.3/10) from $147/mo — read the review →
Ready to start GLP-1 weight loss?
Our verdict for this matchup is Oak.
Frequently asked questions
Which is better, Oak or Embody?
Oak scores higher overall (7.7/10 vs 7.2/10) and is our recommended pick for most people. If price is the priority, Embody starts at $79/mo.
How much does Oak cost vs Embody?
Oak is from $119/mo and Embody is from $79/mo. Both are typically cash-pay; HSA/FSA funds are often eligible. We run an automated check against each clinic's own live pricing page every week; a price left unconfirmed for 45 days shows as unverified rather than staying marked as current.
What is the difference between Oak and Embody?
Oak (7.7/10, #4 of 30) and Embody (7.2/10, #17 of 30) are scored independently across our 4 criteria: price & value, clinical oversight, medication options and transparency. See the detailed score breakdown above for the criterion-by-criterion comparison.
Does Oak or Embody take insurance?
Neither Oak nor Embody typically accepts insurance for GLP-1 weight-loss treatment. Both operate on a cash-pay model, though HSA and FSA funds are often eligible. Confirm at checkout.
Related comparisons
Top picks
We email you when a price we track changes.
No spam, no daily digest — just the clinics you're comparing, when their verified price moves.
How we score: every clinic is rated on five weighted criteria from documented evidence. Prices checked weekly— see each review for that clinic's own verification status. Scores are never influenced by affiliate commissions. “Visit”/“Try” links may be affiliate links that support our work. Educational information only — not medical advice.